These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21174271)

  • 21. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton pump inhibition: more than only reflux therapy].
    MMW Fortschr Med; 2008 Nov; 150(46):48-9. PubMed ID: 19133361
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects.
    Tsukahara K; Kimura K; Morita S; Ebina T; Kosuge M; Hibi K; Iwahashi N; Endo M; Maejima N; Sugano T; Umemura S
    J Cardiol; 2011 May; 57(3):275-82. PubMed ID: 21371863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NSAID-induced gastrointestinal and cardiovascular injury.
    Ng SC; Chan FK
    Curr Opin Gastroenterol; 2010 Nov; 26(6):611-7. PubMed ID: 20948372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Interaction between clopidogrel and proton pump inhibitors.
    Howard PA; Vacek JL
    Am J Cardiovasc Drugs; 2009; 9(6):353-9. PubMed ID: 19929033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
    Lanas A
    Gastroenterol Hepatol; 2010 Jan; 33(1):1-5. PubMed ID: 20005015
    [No Abstract]   [Full Text] [Related]  

  • 28. Pro: Impedance testing is useful in the management of GERD.
    Blondeau K; Tack J
    Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury.
    Lai LH; Chan FK
    Curr Opin Gastroenterol; 2009 Nov; 25(6):544-8. PubMed ID: 19696667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study.
    van Boxel OS; van Oijen MG; Hagenaars MP; Smout AJ; Siersema PD
    Am J Gastroenterol; 2010 Nov; 105(11):2430-6; quiz 2437. PubMed ID: 20736935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that decrease the effectiveness of clopidogrel.
    Aschenbrenner DS
    Am J Nurs; 2009 Jun; 109(6):66-7. PubMed ID: 19478613
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

  • 35. A review of clinical practice guidelines for reflux disease: toward creating a clinical protocol for the otolaryngologist.
    Altman KW; Prufer N; Vaezi MF
    Laryngoscope; 2011 Apr; 121(4):717-23. PubMed ID: 21298646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achievements in esophagology during 2008.
    Tytgat GN
    Curr Opin Gastroenterol; 2009 Jul; 25(4):339-41. PubMed ID: 19448532
    [No Abstract]   [Full Text] [Related]  

  • 37. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GERD-related chronic laryngitis: pro.
    Ford CN
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):910-3. PubMed ID: 20855685
    [No Abstract]   [Full Text] [Related]  

  • 39. Do you really need that heartburn med?
    Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):4-5. PubMed ID: 20848752
    [No Abstract]   [Full Text] [Related]  

  • 40. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.